Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Alnylam Pharmaceuticals and Canada's Tekmira Pharmaceuticals have formed a research collaboration focused on the discovery of cationic lipids and lipid nanoparticles for the delivery of RNAi therapeutics. Both companies are already advancing RNAi drugs that use Tekmira's stable nucleic acid lipid particle delivery technology. Research will be funded by Alnylam and conducted by scientists at the University of British Columbia and at a newly formed company called AlCana Technologies.
This article has been sent to the following recipient: